23andMe CEO on Trading Debut, GSK Deal, Branson SPAC

Bloomberg Technology published this video item, entitled “23andMe CEO on Trading Debut, GSK Deal, Branson SPAC” – below is their description.

Jun.17 — 23andMe Inc. CEO Anne Wojcicki discusses the DNA-testing company’s NASDAQ trading debut, a collaboration on drug development with GlaxoSmithKline Plc, and the choice to go public through a merger with VG Acquisition Corp., a special-purpose acquisition company founded by billionaire Richard Branson. She speaks with Bloomberg’s Emily Chang on “Bloomberg Markets: The Close.”

Bloomberg Technology YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - Bloomberg Technology

Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City. It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Recent from Bloomberg Technology:

  • Pandemic Creates New Opportunities for Tech Sector
  • SPAC Deal for Digital Freight Start Up
  • Airbnb CEO Says There Will Be a New Golden Age of Travel
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.